Further large-scale and prospective studies are required to elucidate the clinical significance of this autoimmunity in the pathogenesis of AD and to assess the potential role of AAb-IFN-α as a protective self-immune response against the rapid decline of β-cell mass. This evidence concerns the gene IFNA2 and Alzheimer disease.